AdOM (אדום טכנולוגיות אופטיות מתקדמות)
Lod, Israel
AdOM is developing the Tear Film Imager (TFI) for diagnosing dry eye syndrome. Its non-contact technology is designed to quantify measurement of the tear film inner layers, enabling improved diagnosis of dry eye disease within minutes using a resolution of 1 nanometer (1/1,000 micrometer) where the entire film is only 5 micrometers thick and even thinner for patients with dry eye. The hyperspectral technology implemented within the TFI is based on three pillars: spectral imaging, which provides an accurate, nanometer-resolution measurement of the tear film inner layers over time; full-field imaging, which provides quantification of the tissue's 3D structure; and algorithms to resolve the anatomy. AdOM's TFI platform is based on proprietary light-band shaping of a halogen lamp source within a meticulously designed optical system. The image of the tear film provided by the camera is obtained by using a full-field acquisition unit and then analyzed using three algorithmic stages: signal processing, image processing, and modeling.
Company Info
- Founded
- 2003
- Website
- adom-smarthome.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of AdOM (אדום טכנולוגיות אופטיות מתקדמות)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.